


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.38%
-2.75%
+0.67%
-1.48%
CL
Colgate-Palmolive Company
$91.90
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Technical Indicators

Overbought
CL Price Performance
$76.93 (+19.46%)
$76.91 (+19.49%)
$84.28 (+9.04%)
$86.39 (+6.38%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
CL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CL Street Sentiment is extremely bullish and have positive views on the near-term outlook
CL has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 07, 2026
Upgrade
Overweight
Piper Sandler
Jan 06, 2026
Price Target Raised
Overweight
JP Morgan
Dec 19, 2025
Reiterate
Overweight
JP Morgan
Dec 16, 2025
Downgrade
Hold
Argus
Dec 11, 2025
Price Target Raised
Buy
RBC
What is CL current stock price?
What are CL stock strengths?
What is CL Risk Level?
What is CL market cap and volume?
What is CL current Stock IQ?
Should I buy CL stock right now?
Is CL a Strong Buy right now?
What does a 'Strong Buy' rating mean for CL?
What does a 'Strong Sell' rating mean for CL?
What factors influence CL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.38%
-2.75%
+0.67%
-1.48%
CL
Colgate-Palmolive Company
Current Price
$91.90

CL Price Performance
$76.93 (+19.46%)
$76.91 (+19.49%)
$84.28 (+9.04%)
$86.39 (+6.38%)
CL Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market

Trading below its fair value
![]()
CL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CL Street Sentiment is extremely bullish and have positive views on the near-term outlook
CL has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 07, 2026
Upgrade
Overweight
Piper Sandler
Jan 06, 2026
Price Target Raised
Overweight
JP Morgan
Dec 19, 2025
Reiterate
Overweight
JP Morgan
Dec 16, 2025
Downgrade
Hold
Argus
Dec 11, 2025
Price Target Raised
Buy
RBC
CL Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Trading below its fair value
Technical Indicators

Overbought
CL Latest Analysis
Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results. CL) posted better-than-expected fourth-quarter earnings on Friday.The company reported fourth-quarter adjusted earnings per share of 95 cents beating the analyst consensus estimate of 91 cents. Quarterly sales of $5.230 billion beating the Street view of $5.118 billion.Net sales and organic sales grew in every category during the quarter led by strength in oral care and pet nutrition excluding private lab
Today
CL Crosses Above Average Analyst Target. In recent trading shares of Colgate-Palmolive Co. (Symbol: CL) have crossed above the average analyst 12-month target price of $87.37 changing hands for $90.29/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade on
Today
Colgate Q4 Earnings Top Estimates Strong Pricing Drives Results. CLs Q4 earnings beat estimates as strong pricing and brand leadership lifted sales with solid gains in Latin America and resilient global demand.
Fri Jan 30, 2026
Friday Sector Leaders: Consumer Products Healthcare. Looking at the sectors faring best as of midday Friday shares of Consumer Products companies are outperforming other sectors up 0.8%. Within that group Deckers Outdoor Corp. (Symbol: DECK) and Colgate-Palmolive Co. (Symbol: CL) are two large stocks leading the way showing a
Fri Jan 30, 2026
Colgate-Palmolive outlines 1% to 4% organic sales growth target for 2026 amid volatile category trends.
Fri Jan 30, 2026
Fridays ETF Movers: IYK PICK. In trading on Friday the iShares United States Consumer Staples ETF is outperforming other ETFs up about 0.5% on the day. Components of that ETF showing particular strength include shares of Church &. Dwight up about 4.1% and shares of Colgate-palmolive up about 3.9% on the day.
Fri Jan 30, 2026
Colgate-Palmolive Guides FY26 Sales In Line With Estimates. Q4 Results Top Estimates . (RTTNews) - While reporting financial results for the fourth quarter on Friday consumer products major Colgate-Palmolive Co. (CL) initiated its earnings adjusted earnings net sales and organic sales growth guidance for the full-year 2026 based on current spot rates and includ
Fri Jan 30, 2026
Colgate-Palmolive (CL) Q4 Earnings and Revenues Surpass Estimates. Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.02% and 2.79% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Fri Jan 30, 2026
Colgate-Palmolives Core Strength Lifts Q4 Results. CL) came out swinging topping expectations in the fourth quarter as demand Strong execution in oral care and pet nutrition helped the company shrug off pressure in a tougher global backdrop.The company reported fourth-quarter adjusted earnings per share of 95 cents Quarterly sales of $5.230 billion beating the Street view of $5.118 billion.Net sales rose 5.8% during the period. Organic sales increased 2.2% with a 0.9% drag from lower private-la
Fri Jan 30, 2026
Colgate-Palmolive (CL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates. Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended December 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Fri Jan 30, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.